Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 2,226.60 | 2,016.88 | 2,087.41 | 1,581.27 |
Total Revenue | 2,226.60 | 2,016.88 | 2,087.41 | 1,581.27 |
Costof Revenue Total | 451.40 | 473.06 | 524.37 | 415.89 |
Gross Profit | 1,775.20 | 1,543.82 | 1,563.04 | 1,165.38 |
Selling/ General/ Admin Expenses Total | 737.50 | 1,016.91 | 962.59 | 699.12 |
Depreciation/ Amortization | 143.60 | 150.19 | 108.11 | 77.20 |
Other Operating Expenses Total | 428.40 | 37.08 | 37.81 | 29.81 |
Total Operating Expense | 1,760.90 | 1,677.24 | 1,632.88 | 1,222.01 |
Operating Income | 465.70 | 339.64 | 454.53 | 359.25 |
Interest Inc( Exp) Net- Non- Op Total | -294.00 | 37.07 | 204.51 | 330.41 |
Other Net | 69.20 | -0.33 | 0.60 | 2.29 |
Net Income Before Taxes | 505.50 | 343.83 | 474.98 | 394.41 |
Provisionfor Income Taxes | 143.20 | 102.75 | 124.69 | 97.93 |
Net Income After Taxes | 362.30 | 241.08 | 350.29 | 296.48 |
Minority Interest | -4.60 | -2.23 | -5.46 | -4.86 |
Net Income Before Extra Items | 357.70 | 238.85 | 344.83 | 291.62 |
Net Income | 357.70 | 238.85 | 344.83 | 291.62 |
Income Availableto Com Excl Extra Ord | 357.70 | 238.85 | 344.83 | 291.62 |
Income Availableto Com Incl Extra Ord | 357.70 | 238.85 | 344.83 | 291.62 |
Diluted Net Income | 357.70 | 238.85 | 344.83 | 291.62 |
Diluted Weighted Average Shares | 8.32 | 8.31 | 8.29 | 8.27 |
Diluted EPS Excluding Extra Ord Items | 42.98 | 28.74 | 41.57 | 35.25 |
DPS- Common Stock Primary Issue | 24.00 | 12.00 | 12.00 | 20.00 |
Diluted Normalized EPS | 42.98 | 28.67 | 41.63 | 35.26 |
Gain( Loss)on Saleof Assets | - | 8.07 | -6.00 | -1.74 |
Dilution Adjustment | - | - | 0.00 | - |
Dr. Lal Pathlabs Dividend Dr. Lal Pathlabs Bonus Dr. Lal Pathlabs News Dr. Lal Pathlabs AGM Dr. Lal Pathlabs Rights Dr. Lal Pathlabs Splits Dr. Lal Pathlabs Board Meetings Dr. Lal Pathlabs Key Metrics Dr. Lal Pathlabs Shareholdings Dr. Lal Pathlabs Balance Sheet Dr. Lal Pathlabs Cashflow Dr. Lal Pathlabs Q1 Results Dr. Lal Pathlabs Q2 Results Dr. Lal Pathlabs Q3 Results Dr. Lal Pathlabs Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks